[go: up one dir, main page]

PE20071000A1 - Metodos para la preparacion de rapamicina cristalina y para la medicion de la cristalinidad de los compuestos de rapamicina utilizando calorimetria diferencial de barrido - Google Patents

Metodos para la preparacion de rapamicina cristalina y para la medicion de la cristalinidad de los compuestos de rapamicina utilizando calorimetria diferencial de barrido

Info

Publication number
PE20071000A1
PE20071000A1 PE2006001569A PE2006001569A PE20071000A1 PE 20071000 A1 PE20071000 A1 PE 20071000A1 PE 2006001569 A PE2006001569 A PE 2006001569A PE 2006001569 A PE2006001569 A PE 2006001569A PE 20071000 A1 PE20071000 A1 PE 20071000A1
Authority
PE
Peru
Prior art keywords
rapamycin
differential scanning
scanning calorimetry
crystallinity
crystal
Prior art date
Application number
PE2006001569A
Other languages
English (en)
Inventor
Subodh S Deshmukh
Mahmoud Mirmehrabi
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of PE20071000A1 publication Critical patent/PE20071000A1/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N25/00—Investigating or analyzing materials by the use of thermal means
    • G01N25/20—Investigating or analyzing materials by the use of thermal means by investigating the development of heat, i.e. calorimetry, e.g. by measuring specific heat, by measuring thermal conductivity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N25/00—Investigating or analyzing materials by the use of thermal means
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N25/00—Investigating or analyzing materials by the use of thermal means
    • G01N25/20—Investigating or analyzing materials by the use of thermal means by investigating the development of heat, i.e. calorimetry, e.g. by measuring specific heat, by measuring thermal conductivity
    • G01N25/48—Investigating or analyzing materials by the use of thermal means by investigating the development of heat, i.e. calorimetry, e.g. by measuring specific heat, by measuring thermal conductivity on solution, sorption, or a chemical reaction not involving combustion or catalytic oxidation
    • G01N25/4846—Investigating or analyzing materials by the use of thermal means by investigating the development of heat, i.e. calorimetry, e.g. by measuring specific heat, by measuring thermal conductivity on solution, sorption, or a chemical reaction not involving combustion or catalytic oxidation for a motionless, e.g. solid sample
    • G01N25/4866—Investigating or analyzing materials by the use of thermal means by investigating the development of heat, i.e. calorimetry, e.g. by measuring specific heat, by measuring thermal conductivity on solution, sorption, or a chemical reaction not involving combustion or catalytic oxidation for a motionless, e.g. solid sample by using a differential method

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Combustion & Propulsion (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analyzing Materials Using Thermal Means (AREA)

Abstract

SE REFIERE A UN PROCEDIMIENTO DE PURIFICACION DE RAPAMICINA DE PREFERENCIA CCI-779 (TEMSIROLIMUS) CRISTALINA QUE COMPRENDE: A) CALENTAR LA RAPAMICINA SIN PURIFICAR EN ACETATO DE ETILO A 55 C APROX. Y FILTRAR; B) AGREGAR HEPTANOS EN EL CURSO DE UN PERIODO DE 60 MINUTOS APROX. A VELOCIDAD CONSTANTE; C) REDUCIR LA VELOCIDAD DE AGITACION Y ENFRIAR EL PRODUCTO HASTA APROXIMADAMENTE 7 C A 8 C A DIFERENTES VELOCIDADES HASTA LLEGAR A 9 C/HORA; D) FILTRAR EL PRODUCTO PARA OBTENER DICHA RAPAMICINA CRISTALINA. REFERIDA TAMBIEN A UN METODO PARA MEDIR LA CALIDAD DE PARTICULA DE UN COMPUESTO DE RAPAMICINA UTILIZANDO CALORIMETRIA DIFERENCIAL DE BARRIDO DONDE LA CALIDAD DE PARTICULAS ES PROPORCIONAL A LA TEMPERATURA DE FUSION DE CALOR DE DICHA MUESTRA
PE2006001569A 2005-12-07 2006-12-06 Metodos para la preparacion de rapamicina cristalina y para la medicion de la cristalinidad de los compuestos de rapamicina utilizando calorimetria diferencial de barrido PE20071000A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US74800505P 2005-12-07 2005-12-07

Publications (1)

Publication Number Publication Date
PE20071000A1 true PE20071000A1 (es) 2007-10-10

Family

ID=38117222

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2006001569A PE20071000A1 (es) 2005-12-07 2006-12-06 Metodos para la preparacion de rapamicina cristalina y para la medicion de la cristalinidad de los compuestos de rapamicina utilizando calorimetria diferencial de barrido

Country Status (17)

Country Link
US (1) US20070128731A1 (es)
EP (1) EP1957964A2 (es)
JP (1) JP2009518648A (es)
KR (1) KR20080077147A (es)
CN (1) CN101351702A (es)
AR (1) AR058283A1 (es)
AU (1) AU2006322030A1 (es)
BR (1) BRPI0619592A2 (es)
CA (1) CA2630786A1 (es)
CR (1) CR9985A (es)
EC (1) ECSP088519A (es)
IL (1) IL191545A0 (es)
NO (1) NO20082382L (es)
PE (1) PE20071000A1 (es)
RU (1) RU2008120712A (es)
TW (1) TW200736603A (es)
WO (1) WO2007067566A2 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2749807C (en) * 2009-01-21 2015-09-29 Biocon Limited A method for determination of sirolimus stability and process for preparing its stable form
FR2943539B1 (fr) 2009-03-31 2011-07-22 Ethypharm Sa Composition pharmaceutique comprenant un macrolide immunosuppresseur de la famille des limus.
WO2013022418A1 (en) * 2011-08-05 2013-02-14 Crucible Intellectual Property Llc Nondestructive method to determine crystallinity in amorphous alloy
WO2013162501A1 (en) * 2012-04-23 2013-10-31 Apple Inc. Non-destructive determination of volumetric crystallinity of bulk amorphous alloy
CN108864149B (zh) 2013-03-15 2022-04-05 生物传感器国际集团有限公司 雷帕霉素衍生物的纯化
US9439892B2 (en) 2013-05-16 2016-09-13 Surmodics, Inc. Macrolide particulates, methods for preparation, and medical devices associated therewith
EP3007679B1 (en) * 2013-06-12 2020-11-11 SurModics, Inc. Solvent methods for preparing crystalline macrolide particulates, compositions, and articles containing particulates
DE102013110294B4 (de) * 2013-09-18 2016-07-07 Innora Gmbh Limus-Depot-Formulierung auf Ballonkathetern
WO2015181826A1 (en) 2014-05-27 2015-12-03 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Crystalline coating and release of bioactive agents
CN105116013A (zh) * 2015-04-23 2015-12-02 山东农业大学 一种确定金属离子对蛋白酶水解大豆分离蛋白影响的方法
JP6531488B2 (ja) * 2015-05-22 2019-06-19 日産自動車株式会社 リチウムイオン二次電池の熱履歴検知方法
US10098846B2 (en) 2016-03-31 2018-10-16 Surmodics, Inc. Drug-containing particulate composition with cationic agent, associated medical devices, and methods for treatment
EP3554571B1 (en) 2016-12-16 2024-11-13 Surmodics, Inc. Hydrophobic active agent particle coatings and methods for treatment
US11629222B2 (en) * 2019-07-01 2023-04-18 Ethicon, Inc. Calorimetric crystallization method for evaluation of monomer purity
WO2023158308A1 (en) 2022-02-18 2023-08-24 Technische Universiteit Delft Novel method for analyzing dsc data
NL2031004B1 (en) * 2022-02-18 2023-09-05 Univ Delft Tech Novel method for analyzing DSC data
CN116794248A (zh) * 2023-04-20 2023-09-22 广东省药品检验所（广东省药品质量研究所、广东省口岸药品检验所） 一种防止压片过程中堵塞机器的共处理晶体辅料评价方法
CN118706889A (zh) * 2024-05-31 2024-09-27 瀚晖制药有限公司 一种阿帕他胺固体制剂结晶度的检测方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA737247B (en) * 1972-09-29 1975-04-30 Ayerst Mckenna & Harrison Rapamycin and process of preparation
US5358909A (en) * 1991-02-27 1994-10-25 Nippon Steel Corporation Method of manufacturing field-emitter
US5358908A (en) * 1992-02-14 1994-10-25 Micron Technology, Inc. Method of creating sharp points and other features on the surface of a semiconductor substrate
GB9313650D0 (en) * 1993-07-01 1993-08-18 Glaxo Group Ltd Method and apparatus for the formation of particles
US5385908A (en) * 1993-11-22 1995-01-31 American Home Products Corporation Hindered esters of rapamycin
US5385909A (en) * 1993-11-22 1995-01-31 American Home Products Corporation Heterocyclic esters of rapamycin
US5362718A (en) * 1994-04-18 1994-11-08 American Home Products Corporation Rapamycin hydroxyesters
EP0884585A3 (de) * 1997-06-06 1999-12-29 Netzsch Gerätebau GmbH Vorrichtung zur Differential-Scanning-Kalorimetrie
GB9826882D0 (en) * 1998-12-07 1999-01-27 Novartis Ag Organic compounds
US6277983B1 (en) * 2000-09-27 2001-08-21 American Home Products Corporation Regioselective synthesis of rapamycin derivatives
ES2177373B1 (es) * 1999-11-26 2003-11-01 Astur Pharma Sa Preparacion de azitromicina en su forma no cristalina
DK1319008T3 (da) * 2000-09-19 2009-02-09 Wyeth Corp Vandoplöselige rapamycinestere
KR20050037477A (ko) * 2001-10-17 2005-04-22 이 아이 듀폰 디 네모아 앤드 캄파니 로터-스테이터 장치와 입자 생성을 위한 방법
US20060169199A1 (en) * 2003-03-31 2006-08-03 Vilmos Keri Crystallization and purification of macrolides
PL1558622T3 (pl) * 2003-07-24 2008-06-30 Teva Gyogyszergyar Zartkoerueen Muekoedoe Reszvenytarsasag Sposób oczyszczania makrolidów
KR20060057605A (ko) * 2003-08-07 2006-05-26 와이어쓰 Ｃｃｉ-779의 위치선택적 합성 방법
AU2004270154A1 (en) * 2003-09-03 2005-03-17 Wyeth Amorphous rapamycin 42-ester with 3-hydroxy-2-(hydroxymethyl)-2-methylpropionic acid and its pharmaceutical compositions containing the same
PL1735321T3 (pl) * 2004-04-14 2009-04-30 Wyeth Corp Proces wytwarzania 42-estrów rapamycyny i 32-estrów FK-506 z kwasem dikarboksylowym, prekursory koniugatów rapamycyny oraz przeciwciała
CA2562952A1 (en) * 2004-04-14 2005-11-10 Wyeth Regiospecific synthesis of rapamycin 42-ester derivatives
CN1993368A (zh) * 2004-08-10 2007-07-04 惠氏公司 Cci－779衍生物和其制备方法
AR052269A1 (es) * 2004-12-20 2007-03-07 Wyeth Corp Analogos de rapamicina, un proceso para su elaboracion y los usos de los mismos en la preparacion de un medicamento para el tratamiento de trastornos neurologicos, proliferativos e inflamatorios.
RU2007119585A (ru) * 2004-12-20 2009-01-27 Вайет (Us) Производные рапамицина и их применение при лечении неврологических заболеваний
RU2007129264A (ru) * 2005-02-09 2009-03-20 Вайет (Us) Полиморф cci-779 и его применение
AU2006218916A1 (en) * 2005-03-02 2006-09-08 Wyeth Recovery of CCI-779 from mother liquors
CN101137659A (zh) * 2005-03-07 2008-03-05 惠氏公司 42-o-（2-羟基）乙基-雷帕霉素的氧杂环庚烷异构体

Also Published As

Publication number Publication date
CR9985A (es) 2008-08-21
TW200736603A (en) 2007-10-01
ECSP088519A (es) 2008-07-30
CN101351702A (zh) 2009-01-21
WO2007067566A2 (en) 2007-06-14
US20070128731A1 (en) 2007-06-07
IL191545A0 (en) 2008-12-29
CA2630786A1 (en) 2007-06-14
AR058283A1 (es) 2008-01-30
NO20082382L (no) 2008-09-04
RU2008120712A (ru) 2010-01-20
WO2007067566A3 (en) 2008-01-24
BRPI0619592A2 (pt) 2016-09-06
AU2006322030A1 (en) 2007-06-14
JP2009518648A (ja) 2009-05-07
EP1957964A2 (en) 2008-08-20
KR20080077147A (ko) 2008-08-21

Similar Documents

Publication Publication Date Title
PE20071000A1 (es) Metodos para la preparacion de rapamicina cristalina y para la medicion de la cristalinidad de los compuestos de rapamicina utilizando calorimetria diferencial de barrido
RU2663769C2 (ru) Способ и устройства для изготовления таблетки
Wu et al. Effects of potassium nitrate on the solid phase transitions of ammonium nitrate particles
AR067402A1 (es) Proceso para obtener un tamano de cristal controlado en compuestos de 3,4-dioxo-1-ciclobuteno 1,2-sustituidos
Sekar et al. Effect of KCl addition on crystal growth and spectral properties of glycine single crystals
Wang et al. A novel L-arginine salt nonlinear optical crystal: L-arginine p-nitrobenzoate monohydrate (LANB)
Jaikumar et al. Synthesis, growth, thermal, optical and mechanical properties of new organic NLO crystal: l-alanine dl-malic acid
JP4787679B2 (ja) 化合物の結晶化過程のモニター方法および結晶の製造方法
Voelker et al. Photochemistry and Hole-Burning of Free-Base Porphin and Chlorin in n-Alkane Hosts at 4.2 K
JP6959022B2 (ja) プロトカテク酸カチオン塩の結晶及びその製造方法
Zhang et al. Growth and properties of two new organic nonlinear optical crystals: Hydroxyethylammonium-L-tartrate monohydrate and hydroxyethylammonium-D-tartrate monohydrate
Ramya et al. Growth and characterization of L-Lysine adipate crystal
Kolomenskii et al. Spontaneous Raman spectra of dipicolinic acid in microcrystalline form
Sreevalsa et al. Investigations on the growth and characterization of l-citrulline oxalate monohydrate single crystal
Natarajan et al. Effect of solvents on the bulk growth of 4-aminobenzophenone single crystals: A potential material for blue and green lasers
Bhagat et al. The Study of Crystal Growth of Struvite in Gel Media
CN112064106B (zh) 制备环磷酸二钾锶晶体的方法及应用
Suresh et al. Studies on the growth, spectral, optical, and thermal aspects of a NLO crystal: L-tryptophan hydrogen selenite (LTHS)
Konstantinova et al. Rapid and effective synthesis of diarylsulfur diimides from substituted anilines and sulfur monochloride
Palaniswamy et al. Effect of PH on the growth and characterization of glycine sodium chloride (GSC) single crystal
Beaurain et al. Growth of piezoelectric single crystals by the flux method
MD3821G2 (ro) Procedeu de obţinere a materialului fotosensibil în bază de semiconductor calcogenic amorf As2(SxSe1-x)3
刘彬文 et al. Syntheses and Single-crystal Structures of New Deficient Compounds in the R_6B_2C_2Q_ (14) Family
Ike et al. Brillouin scattering study of liquid–glass transitions of aminopropanols
Li et al. The structural damage and defects induced by femtosecond laser pulse in ZnSe single crystals

Legal Events

Date Code Title Description
FX Voluntary withdrawal